BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) dropped 2.6% during mid-day trading on Tuesday . The stock traded as low as $0.29 and last traded at $0.29. Approximately 280 shares were traded during mid-day trading, a decline of 77% from the average daily volume of 1,192 shares. The stock had previously closed at $0.30.
BioNxt Solutions Stock Down 2.6 %
The firm has a fifty day simple moving average of $0.37 and a 200-day simple moving average of $0.38. The company has a market cap of $31.94 million, a PE ratio of -5.85 and a beta of 0.94.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last released its quarterly earnings results on Monday, April 22nd. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.01 million during the quarter.
BioNxt Solutions Company Profile
BioNxt Solutions Inc operates as a bioscience company in Germany, Switzerland, Austria, Israel, the United States, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder.
Recommended Stories
- Five stocks we like better than BioNxt Solutions
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Garmin Navigates to New Highs Driven By Wearables Trend
- Consumer Discretionary Stocks Explained
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- What is the Hang Seng index?
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
